Ayalew Tefferi, MD, on Imetelstat as Therapy for Myelofibrosis

2014 ASH Annual Meeting
Tweet this page

Ayalew Tefferi, MD, of the Mayo Clinic, on abstract 634, “Imetelstat, a Telomerase Inhibitor, Therapy for Myelofibrosis: A Pilot Study.”

Advertisement

Advertisement



Advertisement